CClinicalTrials.gg
CompletedNCT02372201MicFFGAH2013Updated Feb 26, 2015

Effects of Fasting and Hydro Colon Therapy Plus Probiotics on GI Microbiota in Intolerances and Irritable Bowel Syndrome

An interventional study of Hydro Colon Therapy plus probiotic in Irritable Bowel Disease, sponsored by University of Vienna. Completed at 1 site in Austria. Open to participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-02-26.

Sponsored by University of Vienna · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Not applicable
Ages
20 Years to 50 Years
Sex
All
01

Study summary

Consequences of Colon Hydrotherapy plus probiotic intervention on composition of GI microbiota and well being are analysed in subjects claiming GI inconveniences due to Irritable Bowel Syndrome or food intolerances.

Read the detailed description

Study objectives: Analysis of consequences of Hydro Colon Therapy plus probiotic intervention on GI microbiota and well being.

Study group: 78 subjects, inclusion criteria: 20-50yrs; under consultation at doctors or nutritionists because of claimed food inconveniences or Irritable Bowel Syndrome. exclusion criteria: antibiotics treatment and specified complex diseases.

Intervention: Hydro colon therapy 2- 5 washes within 3 weeks. probiotic intervention after end of Hydro colon therapy for 6 weeks ( DUOLAC® bacterial strains per capsule: Lactobacillus plantarum, Streptococcus thermophiles, Lactobacillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium lactis, Bifidobacterium longum, and Bifidobacterium breve, fructooligosaccharides, 200 µg folic acid, 2.50 µg vitamin B12 and 55 µg selenium (all amounts corresponding to 100% of daily requirement). Control group: Vitamin B complex: 10µg cobalamin, 450µg folic acid, and 55 µg selenium.

Sample collection: standardized Feces collection, T1, before colon hydrotherapy, T2, immediately after colon hydrotherapy 2-5 washes of fasting ; T3, after six weeks of probiotic or Control intervention Analysis: standardizes food frequency questionnaire before and after intervention.

Feces analysis based on 16 S ribosomal DNA (rDNA) PCR DGGE and quantitative PCR (qPCR) and bioinformatic analysis.

02

Conditions studied

  • Irritable Bowel Disease

Keywords

  • irritable bowel disease
  • microbiota
  • hydro colon therapy
  • food intolerance
03

In context

Intestinal Diseases

963 studies on the registry are indexed under Intestinal Diseases; 176 are open to participants now.

This study's enrollment of 68 is close to the median of 70 across 552 interventional studies indexed under Intestinal Diseases.

Browse Intestinal Diseases studies →

Lead sponsor

University of Vienna is the lead sponsor of 47 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Subjects under consultation at doctors or nutritionists for Inflammatory Bowel Syndrome (IBD) of food intolerances

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Antibiotic therapy 0,5 yrs before start
  • Hormone therapies
  • Malignant diseases
  • Subjects were asked to avoid dietary supplements 4 weeks before and during the study.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
68 participants (actual)

Study arms

  • Experimental
    Hydro Colon Therapy plus probiotic

    Hydro Colon therapy including 2-5 washes in 3 weeks, probiotic intervention for 5 weeks after end of hydro Colon therapy

    Other: Hydro Colon Therapy plus probiotic

Interventions

  • OtherHydro Colon Therapy plus probiotic

    Probiotic intervention was done after 2-5 cycles of hydro colon therapy.

06

What researchers measure

Primary outcomes

  1. microbiota structure, using 16 S ribosomal based gradient electrophoresis ( DGGE)

    Microbiota were analysed for abundance of main microbiota groups and microbiota diversity using 16 S ribosomal based gradient electrophoresis ( DGGE). Abundance is shown in DNA copies/g feces; diversity as number of bands/ sample and by bioinformatic analysis

    Time frame: 7- 8 weeks hydro colon washes plus probiotic

  2. Gastrointestinal comfort, measured by Visual Analog Scale

    Gastrointestinal comfort was analysed by a standardised questionnaire. Pain was measured by Visual Analog Scale

    Time frame: 7- 8 weeks hydro colon washes plus probiotic

07

Study locations

1 site
  • Dep. for Nutritional Sciences, University of Vienna
    Vienna, Select your state 1090, Austria
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 26, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02372201
Lead sponsor
University of Vienna
Responsible party
Univ. Doz. Dr. Alexander Haslberger (Univ. Dozent, University of Vienna) — Principal investigator
First posted
Feb 26, 2015
Start date
Jan 2013
Primary completion
Jun 2014
Completion
Oct 2014
Last update
Feb 26, 2015

Study contacts

Alexander Haslberger
principal investigator · UNIVIE

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion